Sponsor pipeline

Shanghai AbelZeta Ltd. clinical trial pipeline

Get alerts when Shanghai AbelZeta Ltd.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1
2
Phase 1/2
3

Disease areas by active trials

DLBCL (1) · Liver Cancer (1) · Lung Cancer (1) · Multiple Myeloma (1) · Non-Hodgkin Lymphoma (1) · Non-Small Cell Lung Cancer (NSCLC) (1) · Prostate Cancer (1)

Get alerts when Shanghai AbelZeta Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free